Wilmington Healthcare appoints new consultants
October 17, 2019 |
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.
Wilmington Healthcare appoints new consultants
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.
In their new roles, Roger and Sarah will help healthcare business leaders to better understand the NHS’s evolving needs and work in strategic partnership with it, as it continues to implement the Long-term Plan and the delivery of sustainable, high value healthcare.
Roger has worked in healthcare for over 16 years, in both the pharmaceutical industry and the NHS. He has joined Wilmington Healthcare from Bristol-Myers Squibb, where he was Senior Regional Access Manager and led new customer- focused initiatives for the company in cardiology and oncology.
Prior to that, he worked for Pfizer Essential Health as a Clinical Effectiveness Consultant. His NHS experience includes working for the Royal Berkshire NHS Foundation Trust as General/Operations Manager for four years, where he led key hospital directorates, including surgery and medicine.
Sarah has worked in the pharmaceutical industry for 14 years and has wide experience of providing consultancy on market access, strategic partnerships, clinical policy development and government affairs.
Before joining Wilmington Healthcare, Sarah was National Policy and Partnership Lead for AstraZeneca UK’s cardiovascular and renal franchise, and provided strategic insight on NHS policies, commissioning and reimbursement pathways.
Other posts that Sarah has held at AstraZeneca, include National NHS Relations Lead, Cardiovascular & Oncology. Prior to that, she worked for GlaxoSmithKline for four years in roles that included Therapy Specialist for its allergy portfolio.
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in diverse roles within the healthcare sector, Roger and Sarah bring a wealth of knowledge and experience to their new posts.
“They are perfectly placed to help our clients keep pace with the scale and speed of change within the NHS and create compelling propositions. They will be a great asset to our consultancy team, and we’re delighted to be working with them.”
Ends
Notes to Editors
For more information, please contact: Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Interactive Medica and OnMedica. A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool
Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23
The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for...
NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
With a stormy outlook predicted for health and care, Wilmington Healthcare’s Oli Hudson looks at the five critical shifts that pharma should focus on as it navigates its way through...
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria...
We must be candid about our use of healthcare data if we want to win back public trust
As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to...
Wilmington Healthcare appoints new Solutions Director
Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Understanding the role of provider collaboratives
Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Integrated NHS finances: what do they mean for High Cost Drugs?
Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas